1
|
Chen WW, Gao RL, Liu LS, Zhu ML, Wang W,
Wang YJ, Wu ZS, Li HJ, Zheng Z, Jiang LX, et al: Outline of the
report on cardiovascular disease in China, 2014. Chinese
Circulation Journal. 30:617–622. 2015.(In Chinese).
|
2
|
Goedeke L, Aranda JF and
Fernández-Hernando C: MicroRNA regulation of lipoprotein
metabolism. Curr Opin Lipidol. 25:282–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Dangwal S and Thum T: MicroRNA
therapeutics in cardiovascular disease models. Annu Rev Pharmacol
Toxicol. 54:185–203. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Creemers EE, Tijsen AJ and Pinto YM:
Circulating microRNAs: novel biomarkers and extracellular
communicators in cardiovascular disease? Circ Res. 110:483–495.
2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gilad S, Meiri E, Yogev Y, Benjamin S,
Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed
N, et al: Serum microRNAs are promising novel biomarkers. PLoS One.
3:e31482008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Gidlöf O, Andersson P, van der Pals J,
Götberg M and Erlinge D: Cardiospecific microRNA plasma levels
correlate with troponin and cardiac function in patients with ST
elevation myocardial infarction, are selectively dependent on renal
elimination, and can be detected in urine samples. Cardiology.
118:217–226. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Olivieri F, Antonicelli R, Lorenzi M,
D'Alessandra Y, Lazzarini R, Santini G, Spazzafumo L, Lisa R, La
Sala L, Galeazzi R, et al: Diagnostic potential of circulating
miR-499-5p in elderly patients with acute non ST-elevation
myocardial infarction. Int J Cardiol. 167:531–536. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He
J, Qin YW and Jing Q: Circulating microRNA: a novel potential
biomarker for early diagnosis of acute myocardial infarction in
humans. Eur Heart J. 31:659–666. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ren J, Zhang J, Xu N, Han G, Geng Q, Song
J, Li S, Zhao J and Chen H: Signature of circulating microRNAs as
potential biomarkers in vulnerable coronary artery disease. PLoS
One. 8:e807382013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Fichtlscherer S, De Rosa S, Fox H,
Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T,
Müller-Ardogan M, et al: Circulating microRNAs in patients with
coronary artery disease. Circ Res. 107:677–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Jansen F, Yang X, Proebsting S, Hoelscher
M, Przybilla D, Baumann K, Schmitz T, Dolf A, Endl E, Franklin BS,
et al: MicroRNA expression in circulating microvesicles predicts
cardiovascular events in patients with coronary artery disease. J
Am Heart Assoc. 3:e0012492014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Sondermeijer BM, Bakker A, Halliani A, de
Ronde MW, Marquart AA, Tijsen AJ, Mulders TA, Kok MG, Battjes S,
Maiwald S, et al: Platelets in patients with premature coronary
artery disease exhibit upregulation of miRNA340* and miRNA624*.
PLoS One. 6:e259462011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Schulte C and Zeller T: microRNA-based
diagnostics and therapy in cardiovascular disease-summing up the
facts. Cardiovasc Diagn Ther. 5:17–36. 2015.PubMed/NCBI
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
16
|
van Rooij E, Quiat D, Johnson BA,
Sutherland LB, Qi X, Richardson JA, Kelm RJ Jr and Olson EN: A
family of microRNAs encoded by myosin genes governs myosin
expression and muscle performance. Dev Cell. 17:662–673. 2009.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Callis TE, Pandya K, Seok HY, Tang RH,
Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, et al:
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction
in mice. J Clin Invest. 119:2772–2786. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Montgomery RL, Hullinger TG, Semus HM,
Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN and
van Rooij E: Therapeutic inhibition of miR-208a improves cardiac
function and survival during heart failure. Circulation.
124:1537–1547. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Ji X, Takahashi R, Hiura Y, Hirokawa G,
Fukushima Y and Iwai N: Plasma miR-208 as a biomarker of myocardial
injury. Clin Chem. 55:1944–1949. 2009. View Article : Google Scholar : PubMed/NCBI
|
20
|
van Rooij E, Sutherland LB, Qi X,
Richardson JA, Hill J and Olson EN: Control of stress-dependent
cardiac growth and gene expression by a microRNA. Science.
316:575–579. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Liu X, Fan Z, Zhao T, Cao W, Zhang L, Li
H, Xie Q, Tian Y and Wang B: Plasma miR-1, miR-208, miR-499 as
potential predictive biomarkers for acute myocardial infarction: an
independent study of Han population. Exp Gerontol. 72:230–238.
2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Huang Y and Li J: MicroRNA208 family in
cardiovascular diseases: therapeutic implication and potential
biomarker. J Physiol Biochem. 71:479–486. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Xiao J, Shen B, Li J, Lv D, Zhao Y, Wang F
and Xu J: Serum microRNA-499 and microRNA-208a as biomarkers of
acute myocardial infarction. Int J Clin Exp Med. 7:136–141.
2014.PubMed/NCBI
|
24
|
Nabiałek E, Wańha W, Kula D, Jadczyk T,
Krajewska M, Kowalówka A, Dworowy S, Hrycek E, Włudarczyk W, Parma
Z, et al: Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in
acute myocardial infarction and stable coronary heart disease.
Minerva Cardioangiol. 61:627–637. 2013.PubMed/NCBI
|
25
|
Iliopoulos D, Drosatos K, Hiyama Y,
Goldberg IJ and Zannis VI: MicroRNA-370 controls the expression of
microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid
Res. 51:1513–1523. 2010. View Article : Google Scholar : PubMed/NCBI
|
26
|
Motawae TM, Ismail MF, Shabayek MI and
Seleem MM: MicroRNAs 9 and 370 association with biochemical markers
in T2D and CAD Complication of T2D. PLoS One. 10:e01269572015.
View Article : Google Scholar : PubMed/NCBI
|